Tag:
препараты GLP-1
News
Limited effectiveness of weight-loss medications — why don’t GLP-1 drugs work for some patients?
GLP-1 class drugs such as "Ozempic," "Wegovy," and "Mounjaro" have radically transformed obesity treatment. According to clinical trials, most users lose 15–20% of their...
News
“Ozempic Face” and Hair Loss: What We Know About the Potential Side Effects of GLP-1 Medications
In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic®, Wegovy®)and tirzepatide (Mounjaro®), have become among the most widely used medications for the...
News
Ozempic, Wegovy and other GLP-1 agonists: What mistakes do patients make when using these medications?
GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), liraglutide, dulaglutide, and tirzepatide, are currently considered among the most effective pharmacotherapies for the management of obesity....
News
Weight loss drugs may increase the risk of developing osteoporosis and gout
According to new research, GLP-1 class drugs, widely used for diabetes and weight loss, may be linked to an increased risk of developing osteoporosis...